Catalyst Event
Medtronic PLC (MDT) · Other
From Akros U.S. Tech 100 Index (AUT100)
4/29/2026, 12:00:00 AM
Medtronic received U.S. Food and Drug Administration (FDA) approval for the Mosaic Neo mitral valve, its next-generation mitral bioprosthesis, on April 29, 2026.
Korean Translation
메드트로닉은 2026년 4월 29일 차세대 승모판막 생체 인공판막인 Mosaic Neo 승모판막에 대해 미국 식품의약국(FDA)의 승인을 받았음.
Related Recent Events
Honeywell International Inc (HON) · Trading Issue
Honeywell Aerospace spin-off is scheduled to be completed on June 29, 2026, marking the final step in the company's portfolio transformation. The new company will trade under the ticker 'HONA'. This event is scheduled.
6/29/2026, 12:00:00 AM
CrowdStrike Holdings Inc (CRWD) · Earnings Release
First quarter fiscal year 2027 earnings release on 2026-06-09 scheduled, with analyst EPS and revenue estimates forecasted. Importance is Medium as earnings releases are significant catalysts with ≥5% expected impact.
6/9/2026, 12:00:00 AM
Datadog Inc (DDOG) · Other
Datadog's annual conference, DASH, is scheduled to take place in New York City on June 9-10, 2026. Low impact is estimated as conference announcements typically have minimal market effect, scheduled.
6/9/2026, 12:00:00 AM
Cloudflare Inc (NET) · Other
Cloudflare announced it will host an Investor Day on June 9, 2026. Low importance is estimated as investor days provide updates but rarely cause immediate large price swings, scheduled.
6/9/2026, 12:00:00 AM
Honeywell International Inc (HON) · Other
A quarterly dividend of $1.19 per share is scheduled to be paid on June 5, 2026, to shareholders of record as of May 17, 2026. This event is scheduled.
6/5/2026, 12:00:00 AM
Medtronic PLC (MDT) · Earnings Release
Medtronic is scheduled to report its financial results for the fourth quarter and full fiscal year 2026 on June 3, 2026. This event is expected to have a medium impact as earnings reports typically drive significant price volatility scheduled.
6/3/2026, 12:00:00 AM